Drug Information Association Logo

DIA and FDA Host Conference on Cargo and Warehouse Theft of Medical Products

Horsham, PA, USA — Apr 14, 2011

DIA and FDA will host Best Practices for the Prevention of Cargo and Warehouse Theft of FDA Regulated Medical Products and Infant Formula on May 13 in Rockville, MD.

Cargo and warehouse theft of FDA-regulated products, including prescription and over-the-counter medicines, vaccines, medical devices, and infant formula, poses a significant public health risk. This conference will discuss current best practices to ensure progress in reducing the number of cargo thefts by enhancing storage and in-transit security practices and providing a prompt and effective
response when a cargo theft occurs. Session topics include:

  • Responding to Cargo Thefts: An FDA/OCI Perspective
  • Protecting Pharmaceutical Goods in Storage and In-Transit: Trends Identified in Theft Activity 2008–2011
  • Security Requirements/Regulations Impacting the Trucking Industry
  • Cargo Theft Incident Response
  • Partnering to Secure the Supply Chain
  • Supply Chain Security Vulnerabilities for Infant Formula
  • Best Practices for the Prevention of Cargo and Warehouse Theft

“Patients have experienced adverse reactions as a result of ingesting stolen drugs, reactions most likely due to improper storage and handling,” says Ilisa Bernstein, Deputy Director, Office of Compliance, Center for Drug Evaluation & Research (CDER), FDA. “Firms engaged in providing medical products and infant formula to the public need to be prepared to respond effectively when a cargo theft has occurred and have a plan in place to quickly assess the type and amount of product stolen and the potential public health risk presented by the stolen product.”

 

 

 

 ###

ABOUT DIA: DIA is the global connector in the life sciences product development process. Our association of more than 18,000 members builds productive relationships by bringing together regulators, innovators and influencers to exchange knowledge and collaborate in an impartial setting. DIA’s network creates unparalleled opportunities for the exchange of knowledge and has the interdisciplinary experience to prepare for future developments. The dedicated efforts of DIA staff, members and speakers enable DIA to provide a comprehensive catalogue of conferences, workshops, training courses, scientific publications and educational materials. DIA is a global community representing thousands of stakeholders working together to bring safe and effective products to patients. DIA is an independent, nonprofit organization with its global center in Washington, D.C., USA; regional offices covering North and South America (Horsham, Penn., USA); Europe, North Africa and the Middle East (Basel, Switzerland); and Japan (Tokyo), India (Mumbai) and China (Beijing). For more information, visit www.diahome.org.